Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 23, 2026
Why Is STMicroelectronics (STM) Stock Down -16.92% Today?

Why Is STMicroelectronics (STM) Stock Down -16.92% Today?

Key Takeaways

  • STM shares plummeted 16.92% on Thursday, marking the stock's sharpest single-day decline in over a year.
  • The primary catalyst was disappointing Q3 revenue guidance: the company forecast $3.70 billion at the midpoint, falling shy of analyst consensus of roughly $3.76–$3.79 billion.
  • Q2 EBITDA of $679 million also significantly missed expectations of approximately $798 million, overshadowing an otherwise strong top-and-bottom-line beat.
  • The selloff reflects elevated expectations that had been priced in after STM rallied more than 110% year-to-date ahead of the report.
  • Broader European equity markets weakened in sympathy, with technology stocks dragging the Stoxx Europe 600 lower.
  • Traders are now watching whether the company's raised AI datacenter revenue targets and projected Q4 acceleration above $4 billion can restore confidence.

Opening Summary

STM, the global semiconductor leader headquartered in Geneva and traded on the NYSE as an ADR, suffered a punishing 16.92% decline on Thursday. The stock closed the previous session at $65.77 and cratered to approximately $54.64 by mid-afternoon, erasing billions in market capitalization. The rout was triggered by the company's second-quarter earnings report, which — despite beating on both revenue and earnings per share — delivered third-quarter revenue guidance that fell short of heightened analyst expectations. A sharp EBITDA miss further fueled the selloff, as investors who had bid the stock up more than 110% year-to-date rushed to lock in profits.

Q3 Revenue Guidance Miss Shakes Investor Confidence

At the heart of the selloff was STM's forward outlook. For the third quarter of fiscal 2026, management guided for net revenues of approximately $3.70 billion at the midpoint, representing roughly 16% year-over-year growth but landing below the consensus estimate of $3.76–$3.79 billion, depending on the polling source. In an environment where STM shares had already priced in substantial optimism — rallying from around $21 last year to north of $65 — even a modest guidance shortfall proved sufficient to trigger a violent revaluation. As Citi analysts noted, "the stock has more than doubled since January, already reflecting growth expectations... if there is no upward revision momentum, the stock may face near-term pressure."

EBITDA Miss and Margin Pressures

While the Q2 top-line and EPS figures exceeded consensus — revenue of $3.49 billion beat the ~$3.47 billion estimate, and non-GAAP EPS of $0.31 crushed the ~$0.26 consensus — a deeper look exposed cracks. EBITDA came in at $679 million, substantially below the ~$798 million analysts had projected. The shortfall was attributed largely to impairment charges, restructuring costs tied to the company's ongoing manufacturing footprint overhaul, and purchase-price accounting effects from the acquisition of NXPI NXP's MEMS sensor business. Free cash flow also disappointed at approximately $83 million versus a roughly $151 million consensus. These profitability headwinds added weight to the bearish narrative, despite management's bullish long-term messaging.

Lofty Expectations Meet Reality

STM entered this earnings report as one of the semiconductor sector's hottest names. The stock's year-to-date surge of over 110% reflected surging enthusiasm around the company's pivot toward AI datacenter silicon — including power management and optical connectivity chips — and its deepening ties to high-profile customers such as AAPL Apple, TSLA Tesla, and SpaceX. In June, management had pre-announced bullish signals, and the company used Thursday's release to again raise its AI datacenter revenue target to above $1 billion for 2026 and well above $2 billion for 2027. CEO Jean-Marc Chery also forecast Q4 revenue above $4 billion. However, J.P. Morgan analysts concluded the report "did not do enough to significantly lift the stock price," given that the June pre-announcement had already set a high bar.

Sector and Broader Market Context

The rout in STM dragged down European semiconductor peers and weighed on the broader market. France's CAC 40 fell over 1.5%, while Italy's FTSE MIB dropped more than 2%. The Stoxx Europe 600 technology sector was among the worst-performing groups of the session. The selling pressure also coincided with cautious positioning ahead of the European Central Bank's monetary policy decision, which was widely expected to hold rates steady. Notably, TXN Texas Instruments — which also reported strong second-quarter results but faced similarly elevated expectations — saw its shares decline around 5% in sympathy. Trading volume in STM surged well above its daily average, signaling intense institutional repositioning.

Trending AI Robots

For traders seeking to navigate volatile markets with data-driven strategies, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots actively generating signals across thousands of tickers. These bots employ diverse strategies, timeframes, and performance metrics tailored to current market conditions, and only the strongest performers are featured in this dynamically updated section. Whether markets are driven by earnings surprises, macroeconomic shifts, or sector rotations, Tickeron's AI trading technology continuously adapts to identify opportunities. Explore the Trending AI Robots to discover which automated strategies are excelling right now.

What Comes Next for STM

The immediate focus for STM investors shifts to execution. Management's Q4 revenue target above $4 billion — implying growth acceleration driven by AI datacenters and low-Earth-orbit satellite communications — now carries even greater weight as a credibility test. Jefferies analysts suggested the Q3 guidance miss may partially reflect slower iPhone 18 ramp-up timing, but noted that the stronger gross margin guide of 37.0% and the Q4 outlook point toward an improving 2027. Key risks include whether the manufacturing restructuring continues to pressure margins, whether AI datacenter demand sustains its current trajectory, and how the automotive and industrial cyclical recovery unfolds in the second half. With the stock still up substantially year-to-date even after Thursday's plunge, the valuation debate remains front and center.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: STM

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


STM's RSI Oscillator recovers from oversold territory

The RSI Indicator for STM moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In of the 32 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on STM as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STM just turned positive on August 07, 2026. Looking at past instances where STM's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STM advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

STM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

STM moved below its 50-day moving average on July 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for STM crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STM entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.740) is normal, around the industry mean (8.255). P/E Ratio (106.235) is within average values for comparable stocks, (166.349). Projected Growth (PEG Ratio) (0.400) is also within normal values, averaging (1.917). Dividend Yield (0.007) settles around the average of (0.015) among similar stocks. P/S Ratio (3.815) is also within normal values, averaging (48.472).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 189.91B. The market cap for tickers in the group ranges from 13.43K to 5.43T. NVDA holds the highest valuation in this group at 5.43T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 5%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 46%. WOLF experienced the highest price growth at 26%, while LASR experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 49
SMR Rating: 76
Profit Risk Rating: 73
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
STM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a broad range of semiconductor integrated circuits and discrete devices

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
39, Chemin du Champ des Filles
Phone
+41 229292929
Employees
51323
Web
https://www.st.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.